Englebert Financial Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Buy
5,478
+193
+4% +$45K 1.37% 16
2026
Q1
$1.29M Buy
5,285
+7
+0.1% +$1.63K 1.47% 13
2025
Q4
$1.09M Buy
+5,278
New +$1.04M 1.25% 16

Other funds holding JNJ

Englebert Financial Advisers's JNJ Position: Q2 2026 in Review

Englebert Financial Advisers increased its Johnson & Johnson (JNJ) stake by 3.7% in Q2 2026, buying an estimated $45K and bringing the position to 5,478 shares worth $1.39M. The position accounts for 1.37% of the portfolio, ranked #16.

Englebert Financial Advisers first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Englebert Financial Advisers held 5,478 shares of Johnson & Johnson worth $1.39M as of Q2 2026.
  • Englebert Financial Advisers bought 193 Johnson & Johnson shares in Q2 2026, an estimated $45K.
  • Johnson & Johnson made up 1.37% of Englebert Financial Advisers's portfolio in Q2 2026, its #16 holding.
  • Englebert Financial Advisers first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Englebert Financial Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.